SCHEMBL7425567

SCHEMBL7425567

CCCc1c(C(=O)C(C)C)c2ccc(C(N)=O)cc2n1Cc1ccc(Br)cc1Cl

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 2/20 0.36
AGTR1 P30556 1/20 0.34
AGTR2 P50052 1/20 0.34
AKR1A1 P14550 1/20 0.33
AKR1B1 P15121 1/20 0.33
OXER1 Q8TDS5 1/20 0.32
PLA2G2A P14555 3/20 0.32
PPARG P37231 2/20 0.32
DPP4 P27487 1/20 0.32
NPC1 O15118 2/20 0.31
KMT2A Q03164 1/20 0.31
LMNA P02545 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
PARP1 P09874 1/20 0.31
S1PR1 P21453 1/20 0.31
IP6K1 Q92551 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7427469 0.92 AGTR1 (0.40) ALOX5APAGTR1AGTR2AKR1A1AKR1B1
SCHEMBL7420996 0.91 LMNA (0.40) ALOX5APOXER1PPARGKMT2ALMNA
SCHEMBL7425988 0.90 AGTR1 (0.36) ALOX5APAGTR1AGTR2OXER1PLA2G2A
SCHEMBL7420228 0.89 MAPT (0.38) PPARGKMT2ASMN1; SMN2
SCHEMBL7472730 0.89 MEN1 (0.39) ALOX5APKMT2ASMN1; SMN2
SCHEMBL7420923 0.89 AKR1B1 (0.40) AGTR1AGTR2AKR1A1AKR1B1PPARG
SCHEMBL687131 0.88 ALOX5AP (0.47) ALOX5APPLA2G2APPARGDPP4KMT2A
SCHEMBL29611861 0.88 ALOX5AP (0.47) ALOX5APPLA2G2APPARGDPP4KMT2A
SCHEMBL7418596 0.87 MAPT (0.38) ALOX5APPLA2G2APPARGDPP4
SCHEMBL7424199 0.86 PLA2G2A (0.34) ALOX5APAGTR1AGTR2AKR1A1AKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
EP-0820441-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-28 EP disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed